Skip to main content
Clinical Trials/NCT03518944
NCT03518944
Unknown
Not Applicable

Establishing of an Early Warming System of Premature Ovarian Insufficiency

Nanfang Hospital, Southern Medical University1 site in 1 country500 target enrollmentJuly 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Primary Ovarian Insufficiency
Sponsor
Nanfang Hospital, Southern Medical University
Enrollment
500
Locations
1
Primary Endpoint
the change of menstruation situation
Last Updated
7 years ago

Overview

Brief Summary

Premature ovarian insufficiency (POI) is a clinical syndrome defined by loss of ovarian activity before the age of 40 years. The POI guideline development group of ESHRE recommends the following diagnostic criteria: oligo/ amenorrhea for at least 4 months and an elevated follicle stimulating hormone (FSH) level >25 mIU/mL on two occasion >4 weeks apart. Some clinicians and researchers proposed that POI was a progressive disease and there were three stages of POI: occult POI, biochemical POI, overt POI. However, there is lack of reliable indicators to assess the different stages of POI. The present study is to explore the change of menstruation condition, basal follicle-stimulating hormone, anti-müllerian hormone and antral follicle count during the development of POI, and whether those marks can assess the different stages of POI.

Registry
clinicaltrials.gov
Start Date
July 1, 2017
End Date
July 1, 2021
Last Updated
7 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Serum FSH levels ≥10mIU/ml/ serum AMH levels ≤1.0pg/ml/ AFC ≤5, on at least two occasion \>4 weeks apart

Exclusion Criteria

  • Polycystic Ovarian Syndrome
  • other causes of amenorrhea

Outcomes

Primary Outcomes

the change of menstruation situation

Time Frame: Every 3 months from date of recruit until the date of study completion, assessed up to 48 months

Menstrual cycle

the change of serum follicle-stimulating hormone levels

Time Frame: Every 3 months from date of recruit until the date of study completion, assessed up to 48 months

the serum FSH levels between day 2 to day 5 of menstrual cycle

the change of serum anti-mullerian hormone levels

Time Frame: Every 3 months from date of recruit until the date of study completion, assessed up to 48 months

the serum anti-mullerian hormone levels between day 2 to day 5 of menstrual cycle

the change of antral follicle count

Time Frame: Every 3 months from date of recruit until the date of study completion, assessed up to 48 months

Antral follicle count between day 2 to day 5 of menstrual cycle

Study Sites (1)

Loading locations...

Similar Trials